BiancaMed ( ResMed)
Sleep medicine and non-invasive ventilation to diagnose, treat, and manage sleep-disordered breathing.. Learn more
Launch date
Market cap
-
Enterprise valuation
AUD54—81m (Dealroom.co estimates Sep 2009.)
Company register number 372477
Dublin County Dublin (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | 6.6m | 3.1m | 4.2m | 5.8m | 7.0m |
| % growth | - | (53 %) | 36 % | 38 % | 20 % |
| EBITDA | (5.1m) | (2.1m) | 1.5m | 3.4m | - |
| % EBITDA margin | (77 %) | (68 %) | 35 % | 58 % | - |
| Profit | (5.9m) | (3.1m) | <1m | 2.3m | - |
| % profit margin | (90 %) | (98 %) | 12 % | 39 % | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
€2.5m | Series A | ||
$8.7m | Series B | ||
N/A | Acquisition | ||
| Total Funding | AUD17.7m | ||
Related Content
Recent News about BiancaMed ( ResMed)
EditMore about BiancaMed ( ResMed)
EditAt ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.